Literature DB >> 3919304

Critical test of a sister chromatid exchange model for the immunoglobulin heavy-chain class switch.

M Wabl, J Meyer, G Beck-Engeser, M Tenkhoff, P D Burrows.   

Abstract

B lymphocytes may switch from producing an immunoglobulin heavy chain of the mu class to that of the gamma, epsilon or alpha class. To maintain the specificity, the new heavy chain must keep the original variable (V) region; this is achieved by deleting DNA sequences so that the V (consisting of joined VH, diversity (DH) and joining (JH) gene segments) and C (constant) gene segments coding for the new heavy chain are brought into close proximity (reviewed in ref. 5; we do not consider here the mu-delta situation). There are, in principle, three types of chromosomal rearrangements that yield a deletion: rearrangement within a chromatid; unequal sister chromatid exchange (as suggested by Obata et al.); and unequal recombination between chromosomal homologues. We have analysed the arrangement of C mu DNA in clones of the pre-B-cell line 18-81 that switches in vitro from mu to gamma 2b. The clones examined produce either mu, gamma 2b or no immunoglobulin chain. We report here that all the gamma 2b clones had lost at least one copy of C mu and no clones contained three copies of C mu. These findings formally exclude both unequal sister chromatid exchange and recombination between homologues as mechanisms for creating a gene encoding the gamma 2b chain.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919304     DOI: 10.1038/313687a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  11 in total

1.  Linkage mapping of D21S171 to the distal long arm of human chromosome 21 using a polymorphic (AC)n dinucleotide repeat.

Authors:  M B Petersen; J L Weber; S A Slaugenhaupt; A E Kwitek; M G McInnis; A Chakravarti; S E Antonarakis
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

2.  Looping out and deletion mechanism for the immunoglobulin heavy-chain class switch.

Authors:  H M Jäck; M McDowell; C M Steinberg; M Wabl
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  Ku80 is required for immunoglobulin isotype switching.

Authors:  R Casellas; A Nussenzweig; R Wuerffel; R Pelanda; A Reichlin; H Suh; X F Qin; E Besmer; A Kenter; K Rajewsky; M C Nussenzweig
Journal:  EMBO J       Date:  1998-04-15       Impact factor: 11.598

4.  Two distinct immunoglobulin heavy chain isotypes in a primitive, cartilaginous fish, Raja erinacea.

Authors:  F A Harding; C T Amemiya; R T Litman; N Cohen; G W Litman
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

5.  Intrachromosomal recombination mediated by papovavirus large T antigens.

Authors:  L St-Onge; L Bouchard; S Laurent; M Bastin
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  Anomalous rearrangements of the immunoglobulin heavy chain genes in human leukemias support the loop-out mechanism of class switch.

Authors:  M Laffan; L Luzzatto
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

7.  The polydeoxyadenylate tract of Alu repetitive elements is polymorphic in the human genome.

Authors:  E P Economou; A W Bergen; A C Warren; S E Antonarakis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

8.  Isotype switching by a microinjected mu immunoglobulin heavy chain gene in transgenic mice.

Authors:  J Durdik; R M Gerstein; S Rath; P F Robbins; A Nisonoff; E Selsing
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

9.  Homologous chromosome recombination generating immunoglobulin allotype and isotype switch variants.

Authors:  T J Kipps; L A Herzenberg
Journal:  EMBO J       Date:  1986-02       Impact factor: 11.598

10.  Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development.

Authors:  E J Messika; P S Lu; Y J Sung; T Yao; J T Chi; Y H Chien; M M Davis
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.